Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Clasificación en acciones #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Precio por acción
$0.0048
Última sincronización: 2023-05-23
Capitalización bursátil
$132.48K
Cambio (1 día)
-20.00%
Cambio (1 año)
0.00%
País
US
Comercio Pear Therapeutics, Inc. (PEAR)

Categoría

Historial del precio de la acción de Pear Therapeutics, Inc. (PEAR)
Precio más alto de cierre: $0.01 el 2023-05-01

Precio más bajo de cierre: $6.62 el 2021-12-01
Historial del precio de la acción de Pear Therapeutics, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 -99.56%
2022 -75.88%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$73.79 -2.05%
US
$129.57 -33.40%
AU
$60.41 169.79%
US
$54.93 -21.11%
US
$30.49 0.00%
US